PPARA and hyperlipidemia: Earlier reports suggested that docosahexaenoic acid51 and benzafibrate52,53, activators of PPARα and fatty acid oxidation, attenuate postprandial hyperlipidaemia in vivo and lower basal TG secretion in Caco-2 enterocyte cultures.